Taub RN - Search Results

1

Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.

Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, Valentin C, Lee SM, Taub RN. Hesdorffer ME, et al. Among authors: taub rn. Am J Clin Oncol. 2008 Feb;31(1):49-54. doi: 10.1097/COC.0b013e3180684181. Am J Clin Oncol. 2008. PMID: 18376228 Clinical Trial.

2

Peritoneal mesothelioma.

Hesdorffer ME, Chabot J, DeRosa C, Taub R. Hesdorffer ME, et al. Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8. Curr Treat Options Oncol. 2008. PMID: 18841478 Review.

3

Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy.

Leinwand JC, Zhao B, Guo X, Krishnamoorthy S, Qi J, Graziano JH, Slavkovic VN, Bates GE, Lewin SN, Allendorf JD, Chabot JA, Schwartz LH, Taub RN. Leinwand JC, et al. Among authors: taub rn. Ann Surg Oncol. 2013 Dec;20 Suppl 3(Suppl 3):S553-9. doi: 10.1245/s10434-013-2976-8. Epub 2013 May 24. Ann Surg Oncol. 2013. PMID: 23702640 Free PMC article.

4

Recurrence of Optimally Treated Malignant Peritoneal Mesothelioma with Cytoreduction and Heated Intraperitoneal Chemotherapy.

Heller DR, Chiuzan C, Taub RN, Leinwand JC, Greene AM, Bates GE, Chabot JA, Kluger MD. Heller DR, et al. Among authors: taub rn. Ann Surg Oncol. 2017 Dec;24(13):3818-3824. doi: 10.1245/s10434-017-6106-x. Epub 2017 Oct 12. Ann Surg Oncol. 2017. PMID: 29027138

5

Two-Stage Cytoreductive Surgery and Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma: Predictors of Overall Survival in an Intention-to-Treat Series.

Leinwand JC, Taub RN, Chabot JA, Kluger MD. Leinwand JC, et al. Among authors: taub rn. Ann Surg Oncol. 2020 Jul;27(7):2539-2547. doi: 10.1245/s10434-019-08139-4. Epub 2019 Dec 12. Ann Surg Oncol. 2020. PMID: 31832913

6

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma.

Borczuk AC, Taub RN, Hesdorffer M, Hibshoosh H, Chabot JA, Keohan ML, Alsberry R, Alexis D, Powell CA. Borczuk AC, et al. Among authors: taub rn. Clin Cancer Res. 2005 May 1;11(9):3303-8. doi: 10.1158/1078-0432.CCR-04-1884. Clin Cancer Res. 2005. PMID: 15867227

7

Chemotherapy for advanced sarcoma: therapeutic decisions and modalities.

Keohan ML, Taub RN. Keohan ML, et al. Among authors: taub rn. Semin Oncol. 1997 Oct;24(5):572-9. Semin Oncol. 1997. PMID: 9344324 Review.

8

Peritoneal mesothelioma.

Taub RN, Keohan ML, Chabot JC, Fountain KS, Plitsas M. Taub RN, et al. Curr Treat Options Oncol. 2000 Oct;1(4):303-12. doi: 10.1007/s11864-000-0046-5. Curr Treat Options Oncol. 2000. PMID: 12057156 Review.

9

Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.

Kluger MD, Taub RN, Hesdorffer M, Jin Z, Chabot JA. Kluger MD, et al. Among authors: taub rn. Eur J Surg Oncol. 2010 Oct;36(10):997-1003. doi: 10.1016/j.ejso.2010.07.001. Epub 2010 Aug 2. Eur J Surg Oncol. 2010. PMID: 20674253 Clinical Trial.

10

Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.

Leinwand JC, Bates GE, Allendorf JD, Chabot JA, Lewin SN, Taub RN. Leinwand JC, et al. Among authors: taub rn. Ann Surg Oncol. 2013 Apr;20(4):1101-4. doi: 10.1245/s10434-012-2790-8. Epub 2013 Mar 2. Ann Surg Oncol. 2013. PMID: 23456384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters